PFID Applauds Congressional Action on AMR, Calls for Urgent Passage of PASTEUR
- jenniferb35
- 2 days ago
- 2 min read
Feb. 5, 2026 (Washington, D.C.) The Partnership to Fight Infectious Disease (PFID) has released the following statement in support of the Pioneering Antimicrobial Subscriptions To End Upsurging Resistance (PASTEUR) Act:
“Antimicrobial resistance poses one of the defining threats to modern medicine, and the reintroduction of the PASTEUR Act (H.R.7352) offers a pragmatic, substantive path forward.
“The need for urgency is well established. Last fall, a global analysis found a decline in the number of antibacterials in the pipeline as well as a lack of innovation against the toughest superbugs. Only five antibacterials in the pipeline target the most dangerous drug-resistant bacteria. Meanwhile, new drug-resistant infections are actively rising in the U.S. and across the world.
“People undergoing cancer treatment, organ transplantation, and even routine surgeries depend on effective antimicrobials to manage the risk of infection. As the existing pipeline narrows and resistance limits our ability to fight infections, the consequences for these vulnerable populations grow more severe with each passing year.
“History has also shown that infections without vaccines to prevent them or drugs to treat them are major bioterrorism and national security concerns. Addressing unmet antimicrobial need is critical to America’s health and safety in more ways than one.
“The PASTEUR Act would fuel innovation in the development of new and novel antibiotics and antifungals. The legislation, modeled after successful federal investment strategies like Project Bioshield, offers a proven framework to stabilize the antimicrobial ecosystem.
“We applaud the sponsors of the PASTEUR Act for their leadership and urge their colleagues in Congress to quickly support it. Success will require collaboration across industries and advocates spanning public health, national security, and beyond. The reward will be a future in which the treatments Americans depend on today remain effective for generations to come.”
Learn more about antimicrobial resistance (AMR) and the PASTEUR Act:
Comments